NEW YORK | By Ana Fuentes | For Conatus Pharmaceuticals’ CEO Steven J. Mento, starting a company was “the only way to go”. This mid-sized biotech company just listed on Nasdaq market place with clinical trials in the U.S. and Europe believes they can do some things better than the big guys in their sector. He speaks with The Corner about investment opportunities and today’s economic challenges.